Publication | Open Access

Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)–mediated signaling pathway

Tumor BiologyPharmacologic InhibitionLung InflammationMedicineEsophageal Cancer CellsPharmacologyCell DeathCancer Cell BiologyPulmonary PharmacologyPaclitaxel CytotoxicityAnti-cancer AgentOncologyRadiation OncologyLung CancerCancer Research